Volume 85 Issue 11 | p. 20 | Concentrates
Issue Date: March 12, 2007

Sanofi Unveils Drug To Fight Malaria

Department: Business

Sanofi-Aventis says the first low-cost combination drug to combat malaria will soon be available throughout sub-Saharan Africa. The French drugmaker is working with a medical charity, Drugs for Neglected Diseases Initiative, to sell and distribute the new medicine, ASAQ, at a "no profit-no loss" price. ASAQ combines two of the most effective drugs known to treat malaria, artesunate (AS) and amodiaquine (AQ), and has been endorsed by the World Health Organization. To maximize access, Sanofi won't patent the medicine. This decision allows generic drug companies to manufacture their own inexpensive versions.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment